Evidence map›Paper›PMID 42199934›Full record

ArticleGynecologic oncology reports2026

Navigating the healthcare system with a

Tina Karimaghaie, Emily M Webster, Sarah R Levi, Stephanie V Blank, Christine Walsh, Lauren B Davis Rivera, Jaime Gilliland, Audra Vanroboys, Max Kirby, Muhammad Danyal Ahsan and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Lights genes action: Video strategy forGynecologic oncology reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tina KarimaghaieGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Emily M WebsterDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, NewYork-Presbyterian Hospital / 525 E 68th Street, Suite J-130, New York, NY 10065, USA.
Sarah R LeviDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, NewYork-Presbyterian Hospital / 525 E 68th Street, Suite J-130, New York, NY 10065, USA.
Stephanie V BlankDivision of Gynecologic Oncology, Icahn School of Medicine at Mount Sinai / 325 W 15th Street, New York, NY 10011, USA.
Christine WalshDivision of Gynecologic Oncology, University of Colorado Anschutz School of Medicine / 1635 Aurora Ct, Anschutz Outpatient Pavilion, 3rd Floor, Aurora, CO 80045, USA.
Lauren B Davis RiveraDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, NewYork-Presbyterian Hospital / 525 E 68th Street, Suite J-130, New York, NY 10065, USA.
Jaime GillilandDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center / 1275 York Avenue, New York, NY 10065, USA.
Audra VanroboysGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Max KirbyGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Muhammad Danyal AhsanGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Steve LopezGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Sophia SharafGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Emily S EpsteinGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Annie EllisOvarian Cancer Research Alliance / 45 Rockefeller Plaza, 20th Floor, New York, NY 10111, USA.
Melissa K FreyGenetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Purpose: Methods: Individuals with self-reported Results: Thirty individuals visited the survey website with 90% (27) completion. Median age was 45 years (IQR, 38-68); 23 (85%) identified as non-Hispanic White, 3 (11%) Hispanic White, and 1 (4%) non-Hispanic Black. All participants identified as female. Participants valued a single clinician/institution managing Conclusion: Individuals with self-reported

Indexed as

BRCA1BRCA2Cancer preventionCentralized careHereditary cancerPatient preferences

Identifiers

PMID42199934
PMCPMC13199661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.